Classification and Pathogenesis of Meningococcal Infections
Abstract
The clinical symptoms induced by Neisseria meningitidis reflect compartmentalized intravascular and intracranial bacterial growth and inflammation. In this chapter, we describe a classification system for meningococcal disease based on the nature of the clinical symptoms. Meningococci invade the subarachnoid space and cause meningitis in as many as 50-70% of patients. The bacteremic phase is moderate in patients with meningitis and mild systemic meningococcemia but graded high in patients with septic shock. Three landmark studies using this classification system and comprising 862 patients showed that 37-49% developed meningitis without shock, 10-18% shock without meningitis, 7-12% shock and meningitis, and 18-33% had mild meningococcemia without shock or meningitis. N. meningitidis lipopolysaccharide (LPS) is the principal trigger of the innate immune system via activation of the Toll-like receptor 4-MD2 cell surface receptor complex on myeloid and nonmyeloid human cells. The intracellular signals are conveyed via MyD88-dependent and -independent pathways altering the expression of >4,600 genes in target cells such as monocytes. However, non-LPS molecules contribute to inflammation, but 10-100-fold higher concentrations are required to reach the same responses as induced by LPS. Activation of the complement and coagulation systems is related to the bacterial load in the circulation and contributes to the development of shock, organ dysfunction, thrombus formation, bleeding, and long-term complications in patients. Despite rapid intervention and advances in patient intensive care, why as many as 30% of patients with systemic meningococcal disease develop massive meningococcemia leading to shock and death is still not understood.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bacterial meningitis can be caused by gram-negative bacteria, such as Neisseria meningitidis, often resulting in long-term cognitive problems, and much of the pathology has been attributed to endotoxin.
“Bacterial meningitis can be caused by gram-negative bacteria, such as Neisseria meningitidis, infecting the brain meninges, often resulting in long-term cognitive problems, and much of the pathology has been attributed to endotoxin [107].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [107]
Cites
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popović, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,177 · see citing works
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978 · see citing works
Self-citationPeptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2
Girardin, S. E., Travassos, L. H., Hervé, M., Blanot, D., Boneca, I. G., Philpott, D. J., Sansonetti, P. J., & Mengin‐Lecreulx, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307198200 · Cited by 684 · see citing works
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144-166.2000 · Cited by 585 · see citing works
Self-citationBrandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A. K., Bruun, J. N., Halvorsen, S., & Sorensen, E. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.2.195 · Cited by 553 · see citing works
Self-citationThe Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Lefkowitz, L. B., Cartter, M. L., Danila, R., Cieslak, P. R., Shutt, K. A., Popović, T., Schuchat, A., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315158 · Cited by 449 · see citing works
Meningococcal carriage and disease—Population biology and evolution
Caugant, D. A., & Maiden, M. C. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.061 · Cited by 387 · see citing works
Meningitis bacterium is viable without endotoxin
Steeghs, L., den Hartog, R., den Boer, A., Zomer, B., Roholl, P. J. M., & van der Ley, P. (1998) · Nature · doi:10.1038/33046 · Cited by 287 · see citing works
Dávila, S., Khor, C. C., Lim, C. C., Hibberd, M. L., Wright, V. J., Inwald, D. P., Nadel, S., Betts, H., Levin, M., Sim, K. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.640 · Cited by 284 · see citing works
Pathogenic neisseriae: surface modulation, pathogenesis and infection control
Virji, M. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2097 · Cited by 267 · see citing works
Zughaier, S. M., Zimmer, S. M., Datta, A., Carlson, R. W., & Stephens, D. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2940-2950.2005 · Cited by 240 · see citing works
van der Ley, P., Steeghs, L., Hamstra, H.-J., ten Hove, J., Zomer, B., & van Alphen, L. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.5981-5990.2001 · Cited by 215 · see citing works
Complement Activation and Endotoxin Levels in Systemic Meningococcal Disease
Brandtzaeg, P., Mollnes, T. E., & Kierulf, P. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.1.58 · Cited by 200 · see citing works
Self-citationTHE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS
Flexner, S. (1913) · The Journal of Experimental Medicine · doi:10.1084/jem.17.5.553 · Cited by 179 · see citing works
The role of porins in neisserial pathogenesis and immunity
Massari, P., Ram, S., MacLeod, H., et al. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00037-9 · Cited by 177 · see citing works
Mogensen, T. H., Paludan, S. R., Kilian, M., & Østergaard, L. J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105626 · Cited by 176 · see citing works
Factors in the prognosis ofmeningococcal infection
Stiehm, E. R., & Damrosch, D. S. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80250-0 · Cited by 175 · see citing works
EPIDEMIOLOGIC FEATURES OF MENINGOCOCCAL DISEASE
Rosenstein, N. E., Perkins, B. A., Stephens, D. S., et al. (2001) · Cited by 174 · see citing works
Kahler, C. M., & Stephens, D. S. (1998) · Critical Reviews in Microbiology · doi:10.1080/10408419891294216 · Cited by 169 · see citing works
Pridmore, A. C., Wyllie, D. H., Abdillahi, F. A., Steeghs, L., van der Ley, P., Dower, S., & Read, R. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/317647 · Cited by 150 · see citing works
Meningococcal bacterial DNA load at presentation correlates with disease severity
Hackett, S. J. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.86.1.44 · Cited by 148 · see citing works
Structural characterization of the lipid A component of pathogenic Neisseria meningitidis
Kulshin, V. A., Zähringer, U., Lindner, B., Frasch, C. E., Tsai, C. M., Dmitriev, B. A., & Rietschel, E. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.6.1793-1800.1992 · Cited by 144 · see citing works
Stephens, D. S., & Farley, M. M. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.22 · Cited by 138 · see citing works
Brooks, R., Woods, C. W., Benjamin, Jr., & Rosenstein, N. E. (2006) · Clinical Infectious Diseases · doi:10.1086/504804 · Cited by 124 · see citing works
Scholten, R. J. P. M., Kuipers, B., Valkenburg, H. A., et al. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-4-236 · Cited by 117 · see citing works
Severity of Meningococcal Disease Associated with Genomic Bacterial Load
Darton, T. C., Guiver, M., Naylor, S. C., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596707 · Cited by 114 · see citing works
Øvstebø, R., Brandtzaeg, P., Brusletto, B. S., Haug, K. B. F., Lande, K., Høiby, E. A., & Kierulf, P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.2980-2987.2004 · Cited by 111 · see citing works
Self-citationRapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.
van Deuren, M., van Dijke, B. J., Koopman, R. J. J., Horrevorts, A. M., Meis, J. F. G. M., Santman, F. W., & van der Meer, J. W. (1993) · BMJ · doi:10.1136/bmj.306.6887.1229 · Cited by 103 · see citing works
Invited review: Neisseria meningitidis lipopolysaccharides in human pathology
Brandtzaeg, P., Bjerre, A. K., Øvstebø, R., Brusletto, B. S., Joø, G. B., & Kierulf, P. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070060401 · Cited by 99 · see citing works
Self-citationHost genetics and outcome in meningococcal disease: a systematic review and meta-analysis
Brouwer, M. C., Read, R. C., & van de Beek, D. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70045-1 · Cited by 88 · see citing works
Ingalls, R., Lien, E., & Golenbock, D. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2230-2236.2001 · Cited by 83 · see citing works
Fransen, F., Heckenberg, S. G. B., Hamstra, H.-J., Feller, M., Boog, C. J. P., van Putten, J. P. M., van de Beek, D., ENDE, A. V. D., & van der Ley, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000396 · Cited by 76 · see citing works
Haralambous, E., Dolly, S. O., Hibberd, M. L., et al. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600643203 · Cited by 75 · see citing works
Contributions ofNeisseria meningitidisLPS and non-LPS to proinflammatory cytokine response
Sprong, T., Stikkelbroeck, N. M. M. L., van der Ley, P., Steeghs, L., van Alphen, L., Klein, N. J., Netea, M. G., van der Meer, J. W. M., & van Deuren, M. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.2.283 · Cited by 70 · see citing works
Gene Expression Pattern in Human Brain Endothelial Cells in Response to Neisseria meningitidis
Schubert‐Unkmeir, A., Sokolova, O. V., Panzner, U., Eigenthaler, M., & Frosch, M. (2006) · Infection and Immunity · doi:10.1128/iai.01508-06 · Cited by 66 · see citing works
Lipooligosaccharide-Deficient Neisseria meningitidis Shows Altered Pilus-Associated Characteristics
Albiger, B., Johansson, L., & Jonsson, A. (2002) · Infection and Immunity · doi:10.1128/iai.71.1.155-162.2003 · Cited by 63 · see citing works
Innate Immune Responses of Synthetic Lipid A Derivatives of Neisseria meningitidis
Zhang, Y., Gaekwad, J., Wolfert, M. A., et al. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200701165 · Cited by 63 · see citing works
Harrison, O. B., Robertson, B. D., Faust, S. N., Jepson, M. A., Goldin, R. D., Levin, M., & Heyderman, R. S. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5193-5201.2002 · Cited by 62 · see citing works
Join‐Lambert, O., Morand, P., Carbonnelle, É., Coureuil, M., Bille, E., Bourdoulous, S., & Nassif, X. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.12.004 · Cited by 59 · see citing works
Case Fatality of Meningococcal Disease in Western Norway
Halstensen, A. I., Pedersen, S. H. J., Haneberg, B., et al. (1987) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548709032375 · Cited by 56 · see citing works
Øvstebø, R., Olstad, O. K., Brusletto, B. S., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01625-07 · Cited by 51 · see citing works
Bjerre, A. K., Brusletto, B. S., Mollnes, T. E., Fritzsønn, E., Rosenqvist, E., Wedege, E., Namork, E., Kierulf, P., & Brandtzaeg, P. (2002) · The Journal of Infectious Diseases · doi:10.1086/338269 · Cited by 50 · see citing works
Self-citationWells, D. B., Tighe, P. J., Wooldridge, K. G., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2718-2722.2001 · Cited by 50 · see citing works
Case-fatality ratio of bacterial meningitis in the African meningitis belt: We can do better
Boisier, P., Maïnassara, H. B., Sidikou, F., Djibo, S., Kairo, K. K., & Chanteau, S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.036 · Cited by 48 · see citing works
Hellerud, B. C., Stenvik, J., Espevik, T., Lambris, J. D., Mollnes, T. E., & Brandtzaeg, P. (2008) · Infection and Immunity · doi:10.1128/iai.00195-08 · Cited by 41 · see citing works
Self-citationde Greeff, S. C., de Melker, H. E., Schouls, L. M., Spanjaard, L., & van Deuren, M. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0535-1 · Cited by 39 · see citing works
Pathogenesis and Pathophysiology of Invasive Meningococcal Disease
Brandtzaeg, P. (2006) · doi:10.1002/3527608508.ch21 · Cited by 37 · see citing works
Self-citationZughaier, S. M., AGRAWAL, S., Stephens, D. S., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.039 · Cited by 36 · see citing works
John, C. M., Liu, M., & Jarvis, G. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004887 · Cited by 36 · see citing works
Bjerre, A. K., Brusletto, B. S., Rosenqvist, E., et al. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060060501 · Cited by 35 · see citing works
Tw, G.-D., Høiby, E. A., Schillinger, A., et al. (1983) · PubMed · Cited by 33 · see citing works
Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4
Zimmer, S. M., Zughaier, S. M., Tzeng, Y., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm057 · Cited by 30 · see citing works
Bjerre, A. K., Brusletto, B. S., Øvstebø, R., et al. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103125001559 · Cited by 27 · see citing works
Nitric oxide production in meningococcal disease is directly related to disease severity
Baines, P. B., Stanford, S. J., Bishop‐Bailey, D., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199906000-00050 · Cited by 27 · see citing works
A NEW DYNAMIC PORCINE MODEL OF MENINGOCOCCAL SHOCK
Nielsen, E. W., Hellerud, B. C., Thorgersen, E. B., et al. (2009) · Shock · doi:10.1097/shk.0b013e31819c37be · Cited by 25 · see citing works
Hellerud, B. C., Nielsen, E. W., Thorgersen, E. B., Lindstad, J. K., Pharo, A. M., Tønnessen, T. I., Castellheim, A. G., Mollnes, T. E., & Brandtzaeg, P. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de8c94 · Cited by 19 · see citing works
Self-citationBjerre, A. K., Brusletto, B. S., Øvstebø, R., et al. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090030301 · Cited by 19 · see citing works
Host response to Neisseria meningitidis lacking lipopolysaccharides
Brandtzaeg, P. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.4.589 · Cited by 13 · see citing works
Self-citationMyocardial dysfunction in meningococcal septic shock: No clear answer yet*
van Deuren, M., & Brandtzaeg, P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000174482.51523.96 · Cited by 4 · see citing works
Self-citationBrandtzaeg, P. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780199204854.003.070605_update_004 · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457 · see citing works
Weller, R. O., Sharp, M. M., Christodoulides, M., Carare, R. O., & Møllgård, K. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1809-z · Cited by 222 · see citing works
“LOS is the major component of meningococci that induces leptomeningitis [12], via binding to CD14-Toll-like receptor Fig.”
Background
- Authors
- Brandtzaeg, P., & van Deuren, M.
- Affiliations
- University of Oslo (NO)
- Corresponding author
- Brandtzaeg, Petter
- ORCID
- Brandtzaeg, Petter
- Venue
- Methods in Molecular Biology
- Publisher
- Humana Press
- Published
- 2011-09-09
- Volume
- 799
- Pages
- 21-35
- ISSN
- 1064-3745 (ISSN-L)
- 1940-6029
- OpenAlex
- W2395880431
- Cited by
- 99
- References
- 60
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 11 · 2017: 7 · 2016: 5 · 2015: 8 · 2014: 9 · 2013: 7 · 2012: 2
- FWCI
- 14.56
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Methods in molecular biology (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Keywords
- Neisseria meningitidis, meningococcal disease, meningitis, septic shock, meningococcal sepsis, disease classification, lipopolysaccharide, TLR4, MyD88 signaling, innate immunity, complement activation, coagulation, organ dysfunction, thrombosis
- MeSH terms
- Animals, Complement Activation, DNA, Bacterial, Humans, Immunity, Innate, Lipopolysaccharides, Meningococcal Infections, Neisseria meningitidis, Research, Shock, Septic, Swine, Waterhouse-Friderichsen Syndrome, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review